CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $6.85 ($35,969)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at $10.39 ($54,558)
- 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 10,000 shares at $10.30 ($103,000)
- 4 Open-market buy Director bought 739,675 shares at $9.39 ($6,945,770)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 400 shares at $24.76 ($9,904)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 27,668 shares at $26.88 ($743,716)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at an average $27.98 ($335,794)
- 4 Open-market sale PRESIDENT AND CEO sold 5,000 shares at an average $30.47 ($152,363)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 5,251 shares at an average $27.90 ($146,510)
- 4 Open-market sale PRESIDENT AND CEO sold 1,085 shares at $30.07 ($32,626)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 12,000 shares at $26.30 ($315,600)
Page 9 of 13 · 244 filings